Compare BRLT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRLT | VTGN |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5M | 24.1M |
| IPO Year | 2021 | 2014 |
| Metric | BRLT | VTGN |
|---|---|---|
| Price | $1.15 | $0.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $1.70 | $0.90 |
| AVG Volume (30 Days) | 62.0K | ★ 681.1K |
| Earning Date | 05-06-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $437,483,000.00 | N/A |
| Revenue This Year | $6.72 | $124.49 |
| Revenue Next Year | $4.95 | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.63 | N/A |
| 52 Week Low | $1.12 | $0.43 |
| 52 Week High | $3.10 | $5.14 |
| Indicator | BRLT | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 53.83 |
| Support Level | N/A | $0.63 |
| Resistance Level | $1.64 | $0.64 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 18.75 | 56.09 |
Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.